Yinzhihuang Injection for Treating Neonatal Jaundice
Author Information
Author(s): Li Junqiang, Zhang Liyu, Chen Zhongguo, Qin Min
Primary Institution: Lincang Maternity and Child Health Hospital, Lincang, Yunnan, China
Hypothesis
This study aims to evaluate the efficacy of Yinzhihuang injection on neonatal hyperbilirubinemia.
Conclusion
Yinzhihuang injection may offer superior benefits compared to routine treatment alone for neonatal hyperbilirubinemia, but further confirmation is needed.
Supporting Evidence
- Twenty-two trials involving 2,714 neonates were included.
- Significant differences were detected for total effective rate and serum bilirubin levels.
- Adverse effects of YZH injection were described in four trials, with an incidence of 8.60%.
Takeaway
This study looked at a medicine called Yinzhihuang to see if it helps babies with yellow skin from jaundice. It seems to work better than just regular treatments.
Methodology
A systematic review and meta-analysis of randomized controlled trials was conducted, analyzing data from multiple databases.
Potential Biases
High risk of bias due to lack of blinding and incomplete outcome data in several studies.
Limitations
The majority of included studies had a high risk of bias and varied in quality, with limited long-term outcome data.
Participant Demographics
Participants were neonates with hyperbilirubinemia, with a mix of male and female infants.
Statistical Information
P-Value
<0.00001
Confidence Interval
95%CI: 1.11 to 1.20
Statistical Significance
p<0.00001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website